97 related articles for article (PubMed ID: 11510986)
1. Tracking prostate carcinoma micrometastasis to multiple organs using histochemical marker genes and novel cell systems.
Culp LA; Holleran JL; Miller CJ
Histol Histopathol; 2001 Jul; 16(3):945-53. PubMed ID: 11510986
[TBL] [Abstract][Full Text] [Related]
2. Tracking micrometastasis to multiple organs with lacZ-tagged CWR22R prostate carcinoma cells.
Holleran JL; Miller CJ; Culp LA
J Histochem Cytochem; 2000 May; 48(5):643-51. PubMed ID: 10769048
[TBL] [Abstract][Full Text] [Related]
3. Differential experimental micrometastasis to lung, liver, and bone with lacZ-tagged CWR22R prostate carcinoma cells.
Holleran JL; Miller CJ; Edgehouse NL; Pretlow TP; Culp LA
Clin Exp Metastasis; 2002; 19(1):17-24. PubMed ID: 11918079
[TBL] [Abstract][Full Text] [Related]
4. Tumor progression, micrometastasis, and genetic instability tracked with histochemical marker genes.
Culp LA; Lin WC; Kleinman NR; Campero NM; Miller CJ; Holleran JL
Prog Histochem Cytochem; 1998; 33(3-4):XI-XV, 329-48. PubMed ID: 10319377
[TBL] [Abstract][Full Text] [Related]
5. Bacterial lacZ gene as a highly sensitive marker to detect micrometastasis formation during tumor progression.
Lin WC; Pretlow TP; Pretlow TG; Culp LA
Cancer Res; 1990 May; 50(9):2808-17. PubMed ID: 2183931
[TBL] [Abstract][Full Text] [Related]
6. Development of micrometastases: earliest events detected with bacterial lacZ gene-tagged tumor cells.
Lin WC; Pretlow TP; Pretlow TG; Culp LA
J Natl Cancer Inst; 1990 Sep; 82(18):1497-503. PubMed ID: 2391720
[TBL] [Abstract][Full Text] [Related]
7. A metastatic human prostate cancer model using intraprostatic implantation of tumor produced by PC-3 neolacZ transfected cells.
Tsingotjidou AS; Ahluwalia R; Zhang X; Conrad H; Emmanouilides C
Int J Oncol; 2003 Dec; 23(6):1569-74. PubMed ID: 14612928
[TBL] [Abstract][Full Text] [Related]
8. T24 HRAS transformed NIH/3T3 mouse cells (GhrasT-NIH/3T3) in serial tumorigenic in vitro/in vivo passages give rise to increasingly aggressive tumorigenic cell lines T1-A and T2-A and metastatic cell lines T3-HA and T4-PA.
Ray DB; Merrill GA; Brenner FJ; Lytle LS; Lam T; McElhinney A; Anders J; Rock TT; Lyker JK; Barcus S; Leslie KH; Kramer JM; Rubenstein EM; Pryor Schanz K; Parkhurst AJ; Peck M; Good K; Granath KL; Cifra N; Detweiler JW; Stevens L; Albertson R; Deir R; Stewart E; Wingard K; Richardson MR; Blizard SB; Gillespie LE; Kriley CE; Rzewnicki DI; Jones DH
Exp Cell Res; 2016 Jan; 340(1):1-11. PubMed ID: 26254261
[TBL] [Abstract][Full Text] [Related]
9. Altered establishment/clearance mechanisms during experimental micrometastasis with live and/or disabled bacterial lacZ-tagged tumor cells.
Lin WC; Culp LA
Invasion Metastasis; 1992; 12(3-4):197-209. PubMed ID: 1294531
[TBL] [Abstract][Full Text] [Related]
10. Improved visualization of lung metastases at single cell resolution in mice by combined in-situ perfusion of lung tissue and X-Gal staining of lacZ-tagged tumor cells.
Arlt MJ; Born W; Fuchs B
J Vis Exp; 2012 Aug; (66):e4162. PubMed ID: 22929213
[TBL] [Abstract][Full Text] [Related]
11. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A
Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of molecular targets on clonal cancer lines derived from a novel hormone-refractory prostate cancer tumor system.
Freedland SJ; Pantuck AJ; Paik SH; Zisman A; Graeber TG; Eisenberg D; McBride WH; Nguyen D; Tso CL; Belldegrun AS
Prostate; 2003 Jun; 55(4):299-307. PubMed ID: 12712409
[TBL] [Abstract][Full Text] [Related]
13. Organ specific Gst-pi expression of the metastatic androgen independent prostate cancer cells in nude mice.
Naiki T; Asamoto M; Toyoda-Hokaiwado N; Naiki-Ito A; Tozawa K; Kohri K; Takahashi S; Shirai T
Prostate; 2012 Apr; 72(5):533-41. PubMed ID: 21748757
[TBL] [Abstract][Full Text] [Related]
14. Tagged tumor cells reveal regulatory steps during earliest stages of tumor progression and micrometastasis.
Culp LA; Lin WC; Kleinman NR
Histol Histopathol; 1999 Jul; 14(3):879-86. PubMed ID: 10425558
[TBL] [Abstract][Full Text] [Related]
15. High-resolution analyses of two different classes of tumor cells in situ tagged with alternative histochemical marker genes.
Lin WC; Pretlow TP; Pretlow TG; Culp LA
Am J Pathol; 1992 Dec; 141(6):1331-42. PubMed ID: 1466397
[TBL] [Abstract][Full Text] [Related]
16. Complementation of two related tumour cell classes during experimental metastasis tagged with different histochemical marker genes.
Lin WC; O'Connor KL; Culp LA
Br J Cancer; 1993 May; 67(5):910-21. PubMed ID: 8494724
[TBL] [Abstract][Full Text] [Related]
17. Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model.
Soff GA; Sanderowitz J; Gately S; Verrusio E; Weiss I; Brem S; Kwaan HC
J Clin Invest; 1995 Dec; 96(6):2593-600. PubMed ID: 8675623
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of fibroblast growth factor 1 in MCF-7 breast cancer cells facilitates tumor cell dissemination but does not support the development of macrometastases in the lungs or lymph nodes.
Zhang L; Kharbanda S; McLeskey SW; Kern FG
Cancer Res; 1999 Oct; 59(19):5023-9. PubMed ID: 10519418
[TBL] [Abstract][Full Text] [Related]
19. Enhanced androgen receptor signaling correlates with the androgen-refractory growth in a newly established MDA PCa 2b-hr human prostate cancer cell subline.
Hara T; Nakamura K; Araki H; Kusaka M; Yamaoka M
Cancer Res; 2003 Sep; 63(17):5622-8. PubMed ID: 14500404
[TBL] [Abstract][Full Text] [Related]
20. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
Igawa T; Lin FF; Rao P; Lin MF
Prostate; 2003 Jun; 55(4):247-58. PubMed ID: 12712404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]